{"id":"https://openalex.org/W7225733186","doi":"https://doi.org/10.25251/xjtnhb68","title":"Efficacy of Risankizumab in Patients with Genital Psoriasis: A Subgroup Analysis by Sex","display_name":"Efficacy of Risankizumab in Patients with Genital Psoriasis: A Subgroup Analysis by Sex","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225733186","doi":"https://doi.org/10.25251/xjtnhb68"},"language":"en","primary_location":{"id":"doi:10.25251/xjtnhb68","doi":"https://doi.org/10.25251/xjtnhb68","is_oa":true,"landing_page_url":"https://doi.org/10.25251/xjtnhb68","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.25251/xjtnhb68","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5135831122","display_name":"Eingun Song","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eingun Song","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079997007","display_name":"Benjamin D. Ehst","orcid":"https://orcid.org/0000-0001-6380-5226","observed_orcids":["https://orcid.org/0000-0001-6380-5226"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin Ehst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108698579","display_name":"Brad P. Glick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brad Glick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161391147","display_name":"George Lewitt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George Lewitt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5144256820","display_name":"Andrew Mastro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Mastro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087549040","display_name":"Phoebe A. Rich","orcid":"https://orcid.org/0000-0002-2294-9466","observed_orcids":["https://orcid.org/0000-0002-2294-9466"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Phoebe Rich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120646479","display_name":"Boussad Ait-Challal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Boussad Ait-Challal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093193852","display_name":"Toni Anschutz","orcid":"https://orcid.org/0009-0004-3594-5028","observed_orcids":["https://orcid.org/0009-0004-3594-5028"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toni Anschutz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089378387","display_name":"Cuiyong Yue","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cuiyong Yue","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124803613","display_name":"Dolly Sharma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dolly Sharma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5065996171","display_name":"Lindsay Ackerman","orcid":"https://orcid.org/0009-0002-3373-3887","observed_orcids":["https://orcid.org/0009-0002-3373-3887"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lindsay Ackerman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"6","first_page":"s805","last_page":"s805"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8499000072479248},{"id":"https://openalex.org/C183021626","wikidata":"https://www.wikidata.org/wiki/Q4620674","display_name":"Sex organ","level":2,"score":0.7346000075340271},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4715000092983246},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.445499986410141},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4318999946117401},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.40860000252723694},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.4047999978065491},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.382999986410141},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3813999891281128},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3441999852657318},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3212999999523163},{"id":"https://openalex.org/C2780276817","wikidata":"https://www.wikidata.org/wiki/Q4116466","display_name":"Genital ulcer","level":5,"score":0.3001999855041504},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2883000075817108},{"id":"https://openalex.org/C2909813250","wikidata":"https://www.wikidata.org/wiki/Q7476596","display_name":"Herpes Genitalis","level":5,"score":0.28209999203681946},{"id":"https://openalex.org/C2909760446","wikidata":"https://www.wikidata.org/wiki/Q12198","display_name":"Sexually transmitted disease","level":4,"score":0.2793000042438507},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.27090001106262207},{"id":"https://openalex.org/C2777700855","wikidata":"https://www.wikidata.org/wiki/Q18211693","display_name":"Vaginal disease","level":3,"score":0.26499998569488525},{"id":"https://openalex.org/C2776173921","wikidata":"https://www.wikidata.org/wiki/Q25326609","display_name":"Dermatology Life Quality Index","level":3,"score":0.26409998536109924},{"id":"https://openalex.org/C3018711458","wikidata":"https://www.wikidata.org/wiki/Q208373","display_name":"Female circumcision","level":2,"score":0.26010000705718994},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.25679999589920044}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25251/xjtnhb68","doi":"https://doi.org/10.25251/xjtnhb68","is_oa":true,"landing_page_url":"https://doi.org/10.25251/xjtnhb68","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25251/xjtnhb68","doi":"https://doi.org/10.25251/xjtnhb68","is_oa":true,"landing_page_url":"https://doi.org/10.25251/xjtnhb68","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Introduction:":[0],"Genital":[1,182,222,261,271],"psoriasis":[2],"(PsO)":[3],"is":[4,85],"considered":[5],"a":[6,86,217,247,285],"high":[7],"impact":[8],"area":[9],"and":[10,25,48,81,128,139,153,168,266,303,315,328,333,349,365,379,400,416,438,443],"qualifies":[11],"patients":[12,57,69,96,106,134,215,245,283,424,460],"for":[13,68,94,214,414],"systemic":[14],"treatment.":[15],"Patients":[16,147],"with":[17,35,58,70,97,107,216,246,284,294,425,433,461],"genital":[18,59,71,99,108,195,207,340,426,441,462],"PsO":[19,72,109,208,223,262,272,442],"often":[20],"have":[21],"increased":[22],"disease":[23],"burden":[24],"reduced":[26,436],"quality":[27,445],"of":[28,50,270,313,318,331,347,352,363,368,377,382,398,403,431,440,446,449,459],"life.":[29],"These":[30],"effects":[31],"may":[32],"be":[33],"compounded":[34],"concerns":[36],"regarding":[37],"engaging":[38],"in":[39,56,73,165,194,203,244,282,339,391,418,456],"sexual":[40,237],"activity.":[41],"The":[42,405],"UnlIMMited":[43,75,83],"clinical":[44],"trial":[45],"assesses":[46],"efficacy":[47,66,154,455],"safety":[49],"risankizumab":[51],"(RZB),":[52],"an":[53],"IL-23":[54],"inhibitor,":[55],"or":[60,100,187],"scalp":[61,101],"PsO.":[62,102,463],"Here":[63],"we":[64],"present":[65],"results":[67],"the":[74,116,136,176,457],"study":[76,93],"stratified":[77,149],"by":[78,150,310,325,344,360,374,395],"sex.":[79,450],"Materials":[80],"Methods:":[82],"(NCT05969223)":[84],"phase":[87],"4,":[88],"multicenter,":[89],"randomized,":[90],"double-blind,":[91],"placebo-controlled":[92,118],"adult":[95],"moderate-to-severe":[98],"This":[103,298],"analysis":[104,167,299],"included":[105,175,300],"(Study-G)":[110],"who":[111],"were":[112,148,156],"originally":[113],"randomized":[114],"during":[115],"double-blind":[117],"period":[119],"to":[120,241,277],"receive":[121],"150":[122,141],"mg":[123,142],"RZB":[124,143,452],"at":[125,131,158],"weeks":[126,430],"0":[127,188,240,322],"4.":[129],"Beginning":[130],"week":[132,159],"16,":[133],"entered":[135],"open-label":[137],"extension":[138],"received":[140],"every":[144],"12":[145],"weeks.":[146],"self-reported":[151],"sex,":[152],"outcomes":[155,174],"reported":[157,343,394,435],"52.":[160],"Safety":[161],"was":[162,292,308,323,342,358,372,393,412],"not":[163],"assessed":[164],"this":[166],"has":[169],"been":[170],"previously":[171],"reported.":[172],"Efficacy":[173],"static":[177],"Physician\u2019s":[178],"Global":[179,268],"Assessment":[180,269],"\u2013":[181,210,224,229],"(sPGA-G)":[183],"0/1":[184,232,257,307,357,371],"(clear/almost":[185],"clear)":[186],"(clear":[189],"skin),":[190],"clinically":[191],"meaningful":[192,337],"improvement":[193,338],"itch":[196,204,209,341],"(assessed":[197],"as":[198],"\u2265":[199,220,250,288,385],"4":[200,242],"point":[201,387],"reduction":[202,388],"from":[205,389,409],"baseline":[206,218,248,286,390,410],"numerical":[211],"rating":[212],"scale":[213],"score":[219,249,287],"4),":[221],"Sexual":[225],"Frequency":[226],"Questionnaire":[227],"(GenPs-SFQ)":[228],"item":[230],"2":[231,356,386],"(PsO":[233],"symptoms":[234,439],"never/rarely":[235],"limit":[236],"activity":[238],"frequency;":[239],"scale)":[243],"2,":[251],"Dermatology":[252],"Life":[253],"Quality":[254],"Index":[255],"(DLQI)":[256],"(no":[258],"impact),":[259],"total":[260,407],"Symptom":[263],"Sale":[264],"(GPSS),":[265],"Patient\u2019s":[267],"(PatGA-G)":[273],"(0":[274],"=":[275,279],"clear":[276],"5":[278],"very":[280],"severe)":[281],"2.":[289],"Missing":[290],"data":[291],"handled":[293],"non-responder":[295],"imputation.":[296],"Results:":[297],"38":[301],"males":[302,314,348,364,378,399,415],"16":[304],"females.":[305,353,369,383,404,419],"sPGA-G":[306,321],"achieved":[309,324,359,373],"84.2%":[311],"(32/38)":[312],"75.0%":[316,366],"(12/16)":[317],"females,":[319,334],"while":[320],"73.7%":[326],"(28/38)":[327],"62.5%":[329],"(10/16)":[330],"male":[332],"respectively.":[335],"Clinically":[336],"85.7%":[345],"(24/28)":[346],"69.2%":[350],"(9/13)":[351],"GenPS-SFQ":[354],"Item":[355],"78.9%":[361],"(15/19)":[362],"(9/12)":[367],"DLQI":[370],"63.2%":[375],"(24/38)":[376],"43.8%":[380],"(7/16)":[381],"A":[384],"PatGA-G":[392],"78.8%":[396],"(26/33)":[397],"76.9%":[401],"(10/13)":[402],"mean":[406],"change":[408],"GPSS":[411],"-35.5":[413],"-35.9":[417],"Conclusions:":[420],"Across":[421],"all":[422],"endpoints":[423],"PsO,":[427],"after":[428],"52":[429],"treatment":[432,453,458],"RZB,":[434],"signs":[437],"improved":[444],"life,":[447],"regardless":[448],"Overall,":[451],"demonstrated":[454]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-11T00:00:00"}